Aytu BioPharma Accounts Payable

Aytu BioPharma (AYTU) currently reports a accounts payable of $13M as of March 2026. That compares with $12M in the prior-year period — up 9.7% year over year. Use the charts on this page to explore Aytu BioPharma's accounts payable history and peer comparisons.

Aytu BioPharma's accounts payable increased from $12M to $13M — a 9.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aytu BioPharma reported $13M in accounts payable as of March 2026. That compares with $12M in the prior-year period — up 9.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aytu BioPharma, and consider following AYTU for alerts when major investors trade the stock.

Aytu BioPharma is classified in the Healthcare sector. On accounts payable, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AYTU with unrelated industries.